Association between Predicted Effects of <i>TP53</i> Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer
Rare germline pathogenic <i>TP53</i> missense variants often predispose to a wide spectrum of tumors characterized by Li-Fraumeni syndrome (LFS) but a subset of variants is also seen in families with exclusively hereditary breast cancer (HBC) outcomes. We have developed a logistic regres...
Main Authors: | Yaxuan Liu, Olga Axell, Tom van Leeuwen, Robert Konrat, Pedram Kharaziha, Catharina Larsson, Anthony P. H. Wright, Svetlana Bajalica-Lagercrantz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/12/6345 |
Similar Items
-
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
by: Meis Omran, et al.
Published: (2020-01-01) -
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
by: Francesco Paduano, et al.
Published: (2021-09-01) -
Germline <i>TP53 </i>Testing in Breast Cancers: Why, When and How?
by: D. Gareth Evans, et al.
Published: (2020-12-01) -
Li–Fraumeni syndrome in adult patients with acute lymphoblastic leukemia
by: Kseniia I. Zarubina, et al.
Published: (2021-07-01) -
Síndrome de Li-Fraumeni
by: Carlos Andrés Ossa, et al.
Published: (2016-06-01)